Quarterly report pursuant to Section 13 or 15(d)

Restructuring

v3.23.3
Restructuring
9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
The Company incurs costs associated with restructuring initiatives intended to improve operating performance, profitability, and working capital levels. Actions associated with these initiatives may include improving productivity, workforce reductions, and the consolidation of facilities.
As of September 30, 2023, the Company does not expect a significant impact of additional charges from restructuring actions in the next 12 months.
The Company’s restructuring expenses are comprised of the following (in millions):
Three Months Ended September 30, 2023
Cost of revenue Selling, general
 and administrative
Total
Severance and employee costs $ —  $ (0.1) $ (0.1)
Other(1)
—  — 
Total $ —  $ (0.1) $ (0.1)
Nine Months Ended September 30, 2023
Cost of revenue Selling, general
 and administrative
Total
Severance and employee costs $ 0.1  $ 1.1  $ 1.2 
Other(1)
—  0.4  0.4 
Total $ 0.1  $ 1.5  $ 1.6 
Three Months Ended September 30, 2022
Cost of revenue Selling, general
 and administrative
Total
Severance and employee costs $ 0.1  $ —  $ 0.1 
Other(1)
—  0.5  0.5 
Total $ 0.1  $ 0.5  $ 0.6 
Nine Months Ended September 30, 2022
(in millions) Cost of revenue Selling, general
 and administrative
Total
Severance and employee costs $ 0.3  $ 1.3  $ 1.6 
Other(1)
0.5  3.3  3.8 
Total $ 0.8  $ 4.6  $ 5.4 
(1) Includes facilities, inventory write-downs, outside services, legal matters, and IT costs.
The following table summarizes restructuring expenses for each reportable segment (in millions):
Three Months Ended Nine Months Ended
September 30, September 30,
2023 2022 2023 2022
Restructuring expenses:
Medical $ —  $ —  $ 0.3  $ 3.0 
Technologies —  0.6  0.2  1.7 
Corporate and other (0.1) —  1.1  0.7 
Total $ (0.1) $ 0.6  $ 1.6  $ 5.4 
The following table summarizes the changes in the Company’s accrued restructuring balance, which are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets (in millions).
Balance at December 31, 2022 $ 1.5 
Restructuring charges 1.6 
Payments (2.8)
Adjustments (0.1)
Balance at September 30, 2023 $ 0.2